Ozempic is licensed for type 2 diabetes

A brand name covers more than the packaging. Ozempic has its own licensed uses, pen types, dosing instructions and research programme. In the UK, doctors prescribe Ozempic for type 2 diabetes alongside diet and exercise. You may take it on its own when metformin does not suit you, or with other diabetes medicines. Your prescription should state which condition is being treated and what improvement your clinician expects to measure.

How semaglutide improves glucose control

Semaglutide acts on GLP-1 receptors. It increases insulin release when glucose is high and cuts unneeded glucagon release. It also affects appetite and slows stomach emptying. These actions help both glucose control and body weight, but the two results do not always arrive together. Your HbA1c may improve well without the weight change you hoped for.

Weight management falls under a different licence

Wegovy also contains semaglutide and holds its own licences for weight management and other uses. Ozempic prescribed only for weight management falls outside its UK diabetes licence. A clinician may prescribe off-label and takes responsibility for that choice. Patients should hear it described as off-label, with no suggestion Ozempic is approved for weight loss. Results from an obesity trial of Wegovy should not be quoted as Ozempic results either.

What your diabetes review should cover

A diabetes review should look at HbA1c, symptoms, weight, kidney function where relevant, side effects and the rest of your medicine list. Your insulin or sulfonylurea may need adjusting, because combining glucose-lowering treatments raises the risk of hypoglycaemia. Do not stop insulin because you have started a new injection. MHRA has reported ketoacidosis where insulin was cut too quickly when GLP-1 treatment began.

Questions to ask before you start

Ask which pen you will get, who will show you how to inject, when your first review is due and who to contact between appointments. Mention any eye disease, past pancreatitis, significant digestive problems, pregnancy plans and any planned anaesthetic. Bring a full medicine list, including supplements. Leave the appointment with a clear plan for missed doses, troublesome symptoms and repeat prescriptions.

Reading news about Ozempic

Check whether a headline is about diabetes treatment, obesity treatment or an observational link. Look for the dose, the comparison treatment and who was studied. A claim like "semaglutide worked" means little without those details. Price and convenience matter, but your treatment decision should also reflect your clinical goals and follow-up. Read the leaflet supplied with your prescription, which remains the reference for your own pack.

HbA1c and glucose readings measure different things

HbA1c reflects your glucose levels over a longer period. A finger-prick or sensor reading covers a much shorter window. Read neither in isolation from your symptoms and your monitoring plan. Ask which measure your team will use to judge Ozempic and when a proper reassessment is due. One good reading does not prove your diabetes is under control. One high result does not automatically mean your dose should go up. Note the circumstances and discuss patterns with your team.

Sources

Your own medicine leaflet and prescriber come first. A source from another country does not mean the same rule applies in the UK.

  1. Ozempic: UK prescribing information medicines.org.uk
  2. MHRA: GLP-1 medicines and rapid insulin reduction gov.uk
  3. MHRA: semaglutide and NAION gov.uk
  4. Wegovy injection: UK prescribing information medicines.org.uk

Spotted something out of date? Report a mistake.